Evidence map›Paper›PMID 35537721›Full record

ArticleSaudi medical journal2022

Immune complex-mediated glomerulonephritis post COVID-19 vaccination in a patient with concomitant Brucellosis.

Saad Al Bakr, Mufaddal A Alaithan

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Saudi medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Saad Al BakrFrom the Internal Medicine and Rheumatology, Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia.
Mufaddal A AlaithanFrom the Internal Medicine and Rheumatology, Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia.
Riyadh Armed Forces Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID vaccinations have been an important step in controlling the COVID-19 pandemic. Despite the fact they were generally safe and effective, a few case reports of renal disorders have been published following COVID vaccines. We report a 29-year-old man with history of Chronic Kidney Disease who presented to our center with flank pain after receiving AstraZeneca COVID vaccine. He also had history of raw milk ingestion. His initial investigations showed high creatinine with high level of proteinuria. A renal biopsy was consistent with immune complex-mediated glomerulonephritis on top of renal fibrosis. His brucella serology also showed high titer. He was started on treatment for Brucellosis and planned for follow-up afterwards for further therapy. To the best of our knowledge, this is the first reported case of concomitant Brucellosis and post COVID vaccine glomerulonephritis.

Indexed as

BrucellosisCOVID-19GlomerulonephritisVaccinesAdultAntigen-Antibody ComplexCOVID-19 VaccinesFemaleHumansMalePandemicsVaccinationAntigen-Antibody ComplexCOVID-19 VaccinesVaccinesbrucellosisChAdOx1 nCoV-19chronicCOVID-19 vaccinesglomerulonephritisrenal insufficiency

Identifiers

PMID35537721
PMCPMC9280603
OpenAlexW4280591468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.